Cardiac Implantable Electronic Device (CIEDs) for Heart Failure in Indonesia: We Have to be More Selective

Ardian Rizal


Cardiac Implantable Electronic Device (CIEDs) had been recommended as an integral part of heart failure management. Despite clear benefits on CIEDs itself, the rate of therapy penetration in Indonesia is still very low. Many contributing factors had been identified, they are lack of physician awareness, lack of referral, and mismatch between national insurance reimbursement and the cost of therapy. We focussed on talking about selective patient selection as one of the most feasible solutions to this problem.


Cardiac Implantable Electronic Device; Heart failure

Full Text:



Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureThe Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016 Jul 14;37(27):2129–200.

Cardiac Resynchronization Therapy: History, Present Status, and Future Directions [Internet]. [cited 2020 Jul 8]. Available from:

Gama Francisco, Ferreira Jorge, Carmo João, Costa Francisco Moscoso, Carvalho Salomé, Carmo Pedro, et al. Implantable Cardioverter–Defibrillators in Trials of Drug Therapy for Heart Failure: A Systematic Review and Meta‐Analysis. J Am Heart Assoc. 2020 Apr 21;9(8):e015177.

Park MY, Altman RK, Orencole M, Kumar P, Parks KA, Heist KE, et al. Characteristics of Responders to Cardiac Resynchronization Therapy: The Impact of Echocardiographic Left Ventricular Volume. Clin Cardiol. 2012 Aug 9;35(12):779–80.

Authors/Task Force Members, Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013 Aug 1;15(8):1070–118.

Van Bommel RJ, Bax JJ, Abraham WT, Chung ES, Pires LA, Tavazzi L, et al. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J. 2009 Oct 1;30(20):2470–7.

Predictors of Appropriate Shocks and Ventricular Arrhythmia in Indonesian with Brugada Syndrome. Indones J Cardiol [Internet]. 2019 Sep 11 [cited 2020 Jul 16];40(2). Available from:

Society APHR: The aphrs white book 2019. http://aphrsorg/publicationshtml (2019). 2019;0:0–0



  • There are currently no refbacks.

Copyright (c) 2020 Ardian Rizal

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.